









시장가
/
주식
/
nasdaq-lnth
/

Lantheus Holdings Inc

LNTH

64.890USD

+0.030+0.05%

종가 02/06, 16:00（ET）시세는 15분 지연됩니다

4.30B시가총액

26.34P/E TTM



Lantheus Holdings Inc

64.890

+0.030+0.05%

개요 금융 분석 회사

개요

금융

분석

회사

자세한 내용은 Lantheus Holdings Inc 회사

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, Neuraceq, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, among others. The Neuraceq (florbetaben F18 injection) is an F-18 PET imaging agent for Alzheimer’s disease.

Lantheus Holdings Inc 정보



종목 코드 LNTH

회사 이름Lantheus Holdings Inc

상장일Jun 25, 2015

CEOMarkison (Brian A)

직원 수808

유형Ordinary Share

회계 연도 종료Jun 25

주소331 Treble Cove Road

도시NORTH BILLERICA

증권 거래소NASDAQ OMX - NASDAQ BASIC

국가United States of America

우편 번호01862

전화19786718001

웹사이트https://www.lantheus.com/

종목 코드 LNTH

상장일Jun 25, 2015

CEOMarkison (Brian A)

Lantheus Holdings Inc의 회사 임원진



이름

이름/직위

직위

주식 보유

변동

Ms. Mary Anne Heino

Executive Chairman of the Board, Interim Executive Officer

599.01K

+14285.00%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+60654.00%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-17901.00%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+2537.00%

Dr. Gerard Ber, Ph.D.

Independent Director

23.36K

+2141.00%

Ms. Minnie Baylor-Henry, J.D.

Independent Director

9.90K

+2537.00%

Dr. Phuong Khanh (P. K.) Morrow, M.D.

Independent Director

3.10K

+2537.00%

Mr. Samuel R. (Sam) Leno

Independent Director

Ms. Julie H. Mchugh

Lead Independent Director

Mr. Gary John Pruden

Independent Director

이름

이름/직위

직위

주식 보유

변동

Ms. Mary Anne Heino

Executive Chairman of the Board, Interim Executive Officer

599.01K

+14285.00%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+60654.00%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-17901.00%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+2537.00%

Dr. Gerard Ber, Ph.D.

Independent Director

23.36K

+2141.00%

Ms. Minnie Baylor-Henry, J.D.

Independent Director

9.90K

+2537.00%

수익 분석

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

사업별USD

이름

수익

비율

PYLARIFY

240.62M

0.00%

DEFINITY

81.78M

0.00%

TechneLite

21.13M

0.00%

Neuraceq

20.44M

0.00%

Strategic partnerships and other

13.71M

0.00%

Other precision diagnostics

6.34M

0.00%

기업이 아직 관련 데이터를 공개하지 않았습니다.

사업별

지역별

사업별USD

이름

수익

비율

PYLARIFY

240.62M

0.00%

DEFINITY

81.78M

0.00%

TechneLite

21.13M

0.00%

Neuraceq

20.44M

0.00%

Strategic partnerships and other

13.71M

0.00%

Other precision diagnostics

6.34M

0.00%

주식 보유 통계

마지막 업데이트: Sun, Jan 11

주주

주주 유형

주주

비율

BlackRock Institutional Trust Company, N.A.

11.00%

Janus Henderson Investors

10.08%

The Vanguard Group, Inc.

10.06%

Morgan Stanley & Co. LLC

5.55%

Farallon Capital Management, L.L.C.

5.24%

기타

58.08%

주주

비율

BlackRock Institutional Trust Company, N.A.

11.00%

Janus Henderson Investors

10.08%

The Vanguard Group, Inc.

10.06%

Morgan Stanley & Co. LLC

5.55%

Farallon Capital Management, L.L.C.

5.24%

기타

58.08%

주주 유형

주주

비율

Investment Advisor

51.50%

Investment Advisor/Hedge Fund

36.38%

Research Firm

8.68%

Hedge Fund

8.11%

Individual Investor

2.40%

Pension Fund

1.78%

Sovereign Wealth Fund

0.77%

Bank and Trust

0.72%

Family Office

0.13%

기관 주식 보유



마지막 업데이트: Thu, Jan 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q4

1029

71.74M

108.19%

-15.56M

2025Q3

1018

78.96M

119.07%

-8.67M

2025Q2

1039

82.20M

120.88%

-4.84M

2025Q1

1066

83.20M

120.27%

-2.89M

2024Q4

1033

78.65M

114.86%

-4.64M

2024Q3

1003

73.69M

106.06%

-7.92M

2024Q2

959

71.82M

103.63%

-10.29M

2024Q1

912

71.21M

103.87%

-11.25M

2023Q4

868

73.50M

107.32%

-9.24M

2023Q3

828

74.80M

109.31%

-3.81M

주주 활동



이름

보유 주식

비율

변동

Chg %

날짜

BlackRock Institutional Trust Company, N.A.

7.29M

11%

-208.45K

-2.78%

Sep 30, 2025

Janus Henderson Investors

6.68M

10.08%

-254.25K

-3.66%

Sep 30, 2025

The Vanguard Group, Inc.

6.92M

10.44%

+100.16K

+1.47%

Sep 30, 2025

Morgan Stanley & Co. LLC

3.68M

5.55%

+3.18M

+635.59%

Sep 30, 2025

Farallon Capital Management, L.L.C.

3.48M

5.24%

+161.00K

+4.85%

Sep 30, 2025

Fidelity Management & Research Company LLC

3.10M

4.68%

-1.03M

-24.93%

Sep 30, 2025

State Street Investment Management (US)

2.50M

3.77%

-61.59K

-2.41%

Sep 30, 2025

Geode Capital Management, L.L.C.

1.75M

2.65%

-22.43K

-1.26%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

1.37M

2.07%

-12.04K

-0.87%

Sep 30, 2025

Reinhart Partners, LLC

1.35M

2.03%

-55.90K

-3.98%

Sep 30, 2025

주식 배당금



지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.

날짜

배당금

기준일

지급일

배당락일

데이터 없음

주식 분할



날짜

배당락일

유형

비율

데이터 없음

날짜

배당락일

유형

비율

데이터 없음

KeyAI



Lantheus Holdings Inc

자세한 내용은 Lantheus Holdings Inc 회사

Lantheus Holdings Inc 정보

Lantheus Holdings Inc의 회사 임원진

수익 분석

주식 보유 통계

기관 주식 보유

주주 활동

관련 ETF

주식 배당금

주식 분할